Skip to main content

stock

LNAI · Lunai Bioworks Inc.

No insider buys or sales filed in 90 days; last 8-K filed Nov 12: executive or director change.

Follow LNAI free

Price

Loading the LNAI chart…

Chart by TradingView

The business

What the company does and what it reports, from its SEC filings.

What it is

As of June 30, 2026, Lunai Bioworks Inc. operated principally through two operating subsidiaries, Renovaro Biosciences and BioSymetrics; a third wholly owned subsidiary, Lunai Bioworks IP, Inc., holds the intellectual property acquired in the May 2026 Neurobridge acquisition, including the N2B intranasal drug delivery platform. BioSymetrics refers to BioSymetrics Inc. and its wholly owned subsidiary BioSymetrics Corp., which were acquired on April 8, 2025. During the quarter ended September 30, 2025, GEDi Cube B.V. ("GEDi Cube"), acquired on February 13, 2024, filed for bankruptcy and ceased operations. Following GEDi Cube's bankruptcy and subsequent deconsolidation, the Company continued pursuing its AI-driven precision medicine and biomarker discovery strategy through BioSymetrics, which had been acquired prior to the bankruptcy.

From the 10-K for the fiscal year ended Jun 30, 2026, filed Oct 13, 2026.

Read the 10-K on SEC
Sector
Life Sciences (SEC office)
Industry
Pharmaceutical Preparations (SIC 2834)
Employees
12
Headquarters
Suite 906 Los Angeles, CA
Incorporated in
DE
Fiscal year ends
June
Exchange
Nasdaq
Fractional shares
No
Listed options
Yes
Filer category
Non-accelerated filer<br>Smaller reporting company
Formerly
RENOVARO INC. (until 2025); RENOVARO BIOSCIENCES INC. (until 2024); Enochian Biosciences Inc (until 2023)
Shares outstanding
5,034,452 as of Oct 13, 2026 (XBRL frame CY2026Q3I)
Filer (SEC EDGAR)
EDGAR filing index

Key stats

Valuation and the ratios that use the live price are free with an account.

Start free to see this

Deep value

NCAV
-$16.93M
NCAV per share
-$3.36
NNWC
-$17.25M
NNWC per share
-$3.43

Expectations

Free cash flow, FY2026
-$5.29M
Free cash growth, last 5 years
—
Revenue growth, last 5 years
—

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
—
ROA
-35.8%

Health

Current ratio
0.1x
Debt/equity
—

Trailing twelve months to Jun 30, 2026; balance sheet at Jun 30, 2026.

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
Jun 30, 2026——-$2.09M-$2.01M
10-K filed Oct 13, 2026
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Mar 31, 2026$20,942$20,942-$1.48M-$2.57M
10-Q filed May 15, 2026
Dec 31, 2025——-$1.82M-$1.80M
10-Q filed May 15, 2026
Assembled from more than one filing; the filing above is only the newest of them.
Sep 30, 2025——-$3.31M$2.82M
10-Q filed May 15, 2026
Assembled from more than one filing; the filing above is only the newest of them.
Jun 30, 2025——-$126.92M-$126.73M
10-K filed Oct 13, 2026
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Mar 31, 2025——-$4.16M$189,176
10-Q filed May 15, 2026
Dec 31, 2024——-$4.55M-$7.25M
10-Q filed May 15, 2026
Assembled from more than one filing; the filing above is only the newest of them.
Sep 30, 2024——-$53.34M-$44.21M
10-Q filed May 15, 2026
Assembled from more than one filing; the filing above is only the newest of them.
Cash
$1.71M
Debt
—
Net cash
—
Current assets
$2.04M
Current liabilities
$18.91M
Working capital
-$16.87M
Total liabilities
$18.97M
Assets
$9.94M
Equity
-$9.02M

Balance as of Jun 30, 2026.

SEC data as of Nov 17, 2026

Earnings moves

No results filings

LNAI has filed no 8-K results release since Oct 6, 2025.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
Jun 30, 2026$51,992-$8.70M-$3.56M-$5.29M
Jun 30, 2025—-$188.97M-$178.01M—
Jun 30, 2024—-$81.64M-$88.43M-$11.04M
Jun 30, 2023—-$38.56M-$39.68M-$11.80M
Jun 30, 2022—-$116.08M-$113.43M-$15.74M
Jun 30, 2021—-$23.40M-$26.72M-$20.66M
Jun 30, 2020—-$11.92M-$11.42M-$10.64M
Jun 30, 2019—-$10.99M-$18.02M-$9.22M
Jun 30, 2018—-$5.33M-$6.31M-$4.37M
Jun 30, 2017—-$2.40M-$2.14M—

What it filed

Material events and 5% ownership filings from the last year.

Company filings

1 offering filing in 12 months

events

  • Executive or director change

    Pay plan change

    Nov 128-K
  • Listing standard noticeExecutive or director changeRegulation FD disclosureOther event

    CFO departure, abrupt

    Oct 228-K
  • Other event
    Oct 98-K
  • Other event
    Jun 178-K
  • Other event
    Jun 168-K
  • Other event
    May 208-K

5% owners ()

Owners and trading

Insider, politician and fund moves, short interest, and the volume traded off the exchange.

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

Short interest

Hard to borrow: Alpaca will not lend it for shorting

  • Shares short

    19,381

  • Of shares outstanding

    0.4%

  • Days to cover

    1.0

  • Change since last report

    -83.4%

Settlement date Oct 30, 2026

Off-exchange short volume, 20 days

42.9%

Through Oct 29, 2026

Of the volume reported to FINRA's off-exchange facilities, market makers' hedging included. It is not short interest.

Short interest and short volume: FINRA

Off-exchange and dark pools

About 13.8% of shares traded off the exchanges

Period ending Oct 30, 2026, FINRA

Week of Oct 12, 2026, published by FINRA 2 to 4 weeks later

  • Dark pools (ATS)10.5%
  • Wholesalers and other dealers89.5%

Venues, week of Oct 12, 2026

Top dark pools

  1. UBSA UBS ATS3,917
  2. EBXL LEVEL ATS3,634
  3. INCR INTELLIGENT CROSS LLC1,665
  4. CGXS ONECHRONOS1,547
  5. SGMT SIGMA X21,322

This shows where shares traded, not who bought or sold. Most off-exchange volume is retail orders filled by wholesalers.

Source: FINRA

Members see

  • Signals: which strategies fired on LNAI, and the evidence behind each
  • Options positioning: the levels dealers are hedged around
  • Technicals: trend and momentum readings
  • Earnings moves: how the price moved after each report
  • News: stories counted once across outlets
Start free to see these

Comments · 0

No comments yet.

Be the first to say something about LNAI.

nakagai

Signals on LNAI come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Follow LNAI free

Not financial advice. Read the terms that govern posting here.